Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Robotic glove aims to give weak hands a grip on daily life

NCT ID NCT05318638

Symptom relief Sponsor: Roessingh Research and Development Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a soft-robotic glove called Carbonhand in 6 people with hand weakness due to aging or neuromuscular disease. The glove supports finger movement to help with daily tasks. Researchers measured how the glove affected movement, pain, and fatigue during strenuous activities. The study was terminated early, so findings are limited.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
soft-robotic glove (Carbonhand system)
What this could lead to
If successful, this glove could help people with weak hands perform daily tasks more easily and with less pain.
What could go wrong
This was a very small, early study (only 6 participants) that was terminated, so results are limited. The glove may cause pain or fatigue in some users.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

6 people

The number who actually took part.

Started

Oct 2022

Finished

Mar 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 90 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Frail elderly with reduced hand function: * Age between 65 and 90 years * Experience difficulties in performing ADL due to a decline in hand function * Able to make a pinch grip between thumb and middle or ring finger * Sufficient cognitive status to understand two-step instructions * Having (corrected to) normal vision * Able to provide written informed consent * Neuromuscular patients: * Age between 18 and 80 years * Experience difficulties in performing ADL due to a decline in hand function that can be attributed to a diagnosed neuromuscular disease * Being in a chronic and stable phase of disease * Able to make a pinch grip between thumb and middle or ring finger * Sufficient cognitive status to understand two-step instructions * Having (corrected to) normal vision * Able to provide written informed consent Exclusion Criteria: * Frail elderly with reduced hand function: * Currently receiving treatment for a disease affecting arm/hand function * Used the CarbonHand system in the past 3 months * Severe sensory problems of the most-affected hand * Severe acute pain of the most-affected hand * Wounds on the hands that can provide a problem when using the glove * Severe contractures limiting passive range of motion * Severe spasticity of the hand (≥2 points on Ashworth Scale) * Insufficient knowledge of the Dutch language to understand the purpose or methods of the study * Neuromuscular patients: * Severe sensory problems of the most-affected hand

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Neuromuscular diseases are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

neuromuscular disease Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Neuromuscular diseases Sarcopenia

Contacts and locations

Locations

  • Roessingh Research and Development

    Enschede, Overijssel, 7522AH, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.